CMPI - Checkmate Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Checkmate Pharmaceuticals's activity chart (see below) currently has 7 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 107.5 days.

Most recent stock forecast was given by KAVERI POHLMAN from BTIG on 20-Apr-2022. First documented stock forecast 01-Sep-2020.

Geoff Meacham Kaveri Pohlman

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Sep-2020

Hold Since 01-Sep-2020

Show more analysts

What is CMPI (Checkmate Pharmaceuticals) average time for price targets to be met?

On average it took 107.5 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on CMPI (Checkmate Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the most public recommendations on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham works at CITI and has 4 price targets and 0 ratings on CMPI

Which analyst is the currently most bullish on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham with highest potential upside - $0

Which analyst is the currently most reserved on CMPI (Checkmate Pharmaceuticals)?

Geoff Meacham with lowest potential downside - -$0